Table 3.
Sample means, between-visit SDs, reliability coefficients (R), and CVs for replicate samples drawn from 2 venipunctures taken 4-8 weeks apart (substudy 3), ARIC Carotid MRI Study 2005-2006
Mean on QC pairs |
Between-visit SD |
R |
CV |
|||||
---|---|---|---|---|---|---|---|---|
% gated | MFI | % gated | MFI | % gated | MFI | % gated | MFI | |
Leukocyte markers | ||||||||
Monocytes | ||||||||
CD14+ | 100.0 | 114.0 | 0.0 | 9.0 | 0.00 | 0.76 | 0.0 | 7.9 |
CD14+/TLR-2+ | 65.0 | 14.1 | 4.7 | 0.5 | 0.84 | 0.90 | 7.3 | 3.4 |
CD14+/TLR-4+ | 64.4 | 16.3 | 3.1 | 0.9 | 0.39 | 0.21 | 4.8 | 5.5 |
CD14+/CD41+/TLR-4+ | 11.1 | 46.7 | 1.6 | 3.8 | 0.77 | 0.64 | 14.8 | 8.2 |
CD14+/CD162+ | 100.0 | 115.0 | 0.0 | 7.0 | 0.00 | 0.75 | 0.0 | 6.1 |
CD14+/TLR-2+/CD162+ | 66.2 | 14.0 | 4.6 | 0.4 | 0.85 | 0.92 | 6.9 | 3.2 |
CD14+/COX-2+ | 98.2 | 16.7 | 2.5 | 2.2 | 0.00 | 0.20 | 2.5 | 13.3 |
CD45+ | 94.1 | 73.9 | 1.5 | 6.3 | 0.67 | 0.43 | 1.6 | 8.5 |
CD45+/MPO+ | 94.1 | 90.6 | 1.5 | 16.3 | 0.67 | 0.52 | 1.6 | 18.0 |
Granulocytes | ||||||||
CD162+ | 99.9 | 81.6 | 0.2 | 10.7 | 0.17 | 0.72 | 0.2 | 13.1 |
MPO+ | — | 850.9 | — | 136.2 | — | 0.39 | — | 16.0 |
Lymphocytes | ||||||||
CD162+ | 88.1 | 54.4 | 2.5 | 3.7 | 0.73 | 0.86 | 2.8 | 6.9 |
Platelet markers | ||||||||
Total platelets CD61+ | 5.2 | 61.6 | 0.6 | 5.1 | 0.94 | 0.93 | 11.6 | 8.2 |
Single platelets CD61+ | 83.4 | — | 3.9 | — | 0.86 | — | 4.6 | — |
CD61+/CD62P+ | 31.5 | 23.3 | 8.9 | 3.0 | 0.71 | 0.91 | 28.2 | 13.1 |
CD41+ | 95.3 | 80.0 | 1.5 | 8.0 | 0.48 | 0.60 | 1.5 | 10.1 |
CD41+/CD154+ | 3.3 | 12.0 | 1.2 | 0.6 | 0.54 | 0.62 | 37.3 | 5.3 |
Cell aggregates | ||||||||
Platelet-monocyte | 17.4 | 47.8 | 2.2 | 3.6 | 0.84 | 0.70 | 12.8 | 7.6 |
Platelet-granulocyte | 17.0 | 49.7 | 2.0 | 3.6 | 0.86 | 0.71 | 11.6 | 7.2 |
Platelet-lymphocyte | 17.0 | 48.5 | 2.1 | 3.7 | 0.84 | 0.75 | 12.5 | 7.5 |
n = 55 replicate pairs. Total platelets include single (activated and nonactivated) platelets and platelet-platelet aggregates. —, measures not available.